Nuclear CXCR4 expression has been observed in several malignant tumors, such as breast cancer [10, 11], colorectal cancer [12], pancreatic adenocarcinoma [13], thyroid carcinoma [14], and prostate cancer [15]. Here, CXCR4 is linked to prostate cancer.